FDA allows Houston cancer doctor to resume drug trial

Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw

Elias Jabbour MD Anderson Cancer Center

Here's who could be helped by new cancer drug — and when

Novartis challenges Pfizer with strong breast cancer drug data

Recent Targeted Therapies Approved for the Treatment of Patients with Urothelial Carcinoma

A Triumph in the War Against Cancer, Science

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial - The Lancet Oncology

Hagop M. Kantarjian MD Anderson Cancer Center

Controversial Texas doctor Stanislaw Burzynski goes before disciplinary board

Stephen Hahn - Wikipedia

Texas judges clear Houston cancer doctor of most medical misconduct charges

Ashish M. Kamat MD Anderson Cancer Center